Headline
The latest stories from AHA Today.
Sens. Chuck Schumer, D-N.Y., Susan Collins, R-Maine, and Andy Kim, D-N.J., June 5 reintroduced the SEPSIS Act (https://www.democrats.senate.gov/imo/media/doc/tam25662pdf.pdf), legislation which would task the Centers for Disease Control and Prevention with continuing its efforts addressing sepsis鈥
The FBI, Cybersecurity and Infrastructure Security Agency and Australian Cyber Security Centre June 4 released an advisory on updated actions and tactics used by the Play ransomware group.
The AHA June 4 filed an amicus brief (/amicus-brief/2025-06-04-aha-files-brief-defending-tennessees-340b-contract-pharmacy-law) in the U.S. District Court for the Middle District of Tennessee in defense of the state鈥檚 340B contract pharmacy law prohibiting drug companies from鈥
The Department of Health and Human Services鈥 Administration for Strategic Preparedness and Response June 5 announced it selected two locations to test an automated, point-of-care, sterile saline manufacturing system that could help prevent or mitigate intravenous fluid shortages in the U.S.
The Food and Drug Administration issued Class I recalls, the most serious type, for two Smiths Medical infusion pumps due to the potential for serious injury or death.
A Congressional Budget Office report released June 4 found that enactment of the fiscal year 2025 budget reconciliation bill, the One Big Beautiful Bill Act (H.R. 1), would lead to 10.9 million people becoming uninsured in 2034 due to significant changes to the Medicaid program and Affordable Care鈥
An article in a special edition of Trustee Insights sponsored by Huron examines five health care trends that boards and executives must pay attention to that can help hospitals and health systems adapt to new changes and requirements.
Duke University鈥檚 Anna Tharakan, lead project manager on Closing the Gap on Hypertension Disparities, and Bradi Granger, Ph.D., research professor at Duke University School of Nursing and director of the Duke Heart Center Nursing Research Program, discuss how Duke鈥檚 team is reducing hypertension鈥
A 60-day appeal window has passed for the Food and Drug Administration to appeal a federal court ruling that invalidated its final rule to regulate laboratory-developed tests as medical devices, effectively eliminating it. The rule, issued last year, would have phased out its general enforcement鈥
The AHA June 3 launched the first in a new video series, 鈥淢edicaid: Real Lives, Real Care,鈥 highlighting the importance of Medicaid and why proposed cuts to the program would jeopardize access to care for patients and communities across America.